About Astrazeneca India Private Limited
Data last updated:
Astrazeneca India Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Astrazeneca Ab. It operates in the business support services segment of the business services sector. It was incorporated on 06 January 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24111TN1986PTC123423. Its GSTIN is 33AABCA2389N1ZH (Tamil Nadu). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹28.97 Cr. It was formerly known as Astra-Idl Biochemicals Pvt Ltd and Astra Biochemicals Pvt Ltd. It is led by directors including Sivakumar Padmanabhan (Managing Director) and Priyanka Mahadevan.
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block A Neville Tower 11th Floor Ramanujan It SEZ Taramani, Chennai, Tamil Nadu, India – 600113.
As per the financials filed for FY 2025, the company reported a revenue of ₹2,087.83 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹250.73 Cr (net margin 12%) and EBITDA of ₹494.19 Cr (EBITDA margin 23.7%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 23% over five years.
The company has about 3,105 employees on its provident fund (EPFO) records.
Court records list 15 cases involving the company, including 9 filed by the company and 6 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website astrazeneca.com.
Company details
Name history
Astrazeneca India has undergone 2 name changes throughout its history. The company was previously known as Astra-Idl Biochemicals Pvt Ltd, and Astra Biochemicals Pvt Ltd. The current legal name is Astrazeneca India Private Limited.
| Company Name | Status |
|---|---|
| Astrazeneca India Private Limited | Current |
| Astra-Idl Biochemicals Pvt Ltd | Previous |
| Astra Biochemicals Pvt Ltd | Previous |
CIN history
Astrazeneca India has one previous CIN (Corporate Identification Number): U24111KA1986PTC007399. The current CIN is U24111TN1986PTC123423, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24111TN1986PTC123423 | Current |
| U24111KA1986PTC007399 | Previous |
Contact details
Astrazeneca India Private Limited's registered office is in Chennai, Tamil Nadu. Its website is astrazeneca.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressBlock A Neville Tower 11th Floor Ramanujan It SEZ Taramani, Chennai, Tamil Nadu, India – 600113
- IndustryBusiness Services, Business Support Services
To see the full contact details of Astrazeneca India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Astrazeneca India is information and communication. In detail, this covers computer programming, consultancy and related activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J6 | Computer programming, consultancy and related activities |
To see the full business activity and turnover split of Astrazeneca India Private Limited, buy the company report.
Financials of Astrazeneca India Private Limited
FY 2025 filings availableAstrazeneca India Private Limited reported revenue of ₹2,087.83 Cr (up 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 35% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹494.19 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹250.73 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.7% | ||||
| Net Profit Margin | 12% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Astrazeneca India Private Limited, buy the company report.
Board of directors of Astrazeneca India Private Limited
Astrazeneca India has 3 current directors and 25 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Mahadevan | Director | 30 Aug 2023 | 3 Years 2 Months | Current |
| Sivakumar Padmanabhan | Managing Director | 18 Sep 2015 | 11 Years 1 Months | Current |
| Praveen Rao Akkinepally Also directs: Astrazeneca Pharma India Limited | Director | 11 Sep 2025 | 1 Years 1 Months | Current |
Auditor
Astrazeneca India Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2023 | 012754N/N500016 |
Shareholding
The shareholding of Astrazeneca India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Astrazeneca India Private Limited, buy the company report.
Legal cases
Astrazeneca India Private Limited has 15 court cases on record: 9 filed by Astrazeneca India, 6 filed against it. 3 cases are pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 11 | 4 | 2 |
| District courts | 4 | 2 | 1 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Appeal | Filed by the company against Ig 3 Infra Limited | Disposed |
| Madras High Court | Civil suit | Filed by the company against Ig 3 Infra Limited | Disposed |
| District court, Chennai, Tamil Nadu | Court case (SOA) | Filed against the company by an individual | Pending |
| High Court, KARNATAKA | Writ petition | Filed by the company against Assistant Commissioner of Central Tax and 2 others | Pending |
| High Court of Karnataka | Tax appeal | Filed against the company by The PR. Commissioner of Income-Tax Cit (A) | Pending |
To see the full case history of Astrazeneca India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Astrazeneca India Private Limited has 9 MSME Form 1 returns on record between 2019 and 2023, listing 42 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Svasth Life Private Limited | |||
| an individual supplier | |||
| Karthik Travels Private Limited | |||
| an individual supplier | |||
| Les Concierges Services Private Limited |
To see the full MSME payment records of Astrazeneca India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Astrazeneca India Private Limited has a workforce of 3,105 employees on its EPFO records as of Sep 25, 2025, across 2 active EPFO establishments.
GST
Astrazeneca India has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCA2389N1ZH | Tamil Nadu | Active | 01 Jul 2017 |
| 33AABCA2389N8ZA | Tamil Nadu | Active | 23 Jan 2025 |
| 29AABCA2389N1Z6 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Astrazeneca India Private Limited, buy the company report.
Recent activity
Astrazeneca India Private Limited has 28 board changes on record since 2011: 4 appointments and 24 cessations. The latest: Praveen Rao Akkinepally ceased to be Additional Director on 18 Sep 2025.
19 earlier events are in the company report.
News
Frequently asked questions
Astrazeneca India is an active private limited company based in Chennai, Tamil Nadu, India. The company works in business support services, within the business services industry. It was incorporated on 06 January 1986 (40+ years old) and is registered under CIN U24111TN1986PTC123423.
Astrazeneca India has 3 current directors:
- Sivakumar Padmanabhan - Managing Director
- Priyanka Mahadevan - Director
- Praveen Rao Akkinepally - Director
The latest financial statements of Astrazeneca India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 19 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Astrazeneca India is 33AABCA2389N1ZH, registered in Tamil Nadu. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 33AABCA2389N8ZA (Tamil Nadu), 29AABCA2389N1Z6 (Karnataka).
The CIN (Corporate Identification Number) of Astrazeneca India is U24111TN1986PTC123423. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astrazeneca India has 15 court cases on record: 9 filed by the company and 6 filed against it. 3 are pending. Most are in the high courts.
Astrazeneca India was incorporated on 06 January 1986, making it 40+ years old. It is registered with the Registrar of Companies, Chennai.
Praveen Rao Akkinepally ceased to be Additional Director on 18 Sep 2025. Praveen Rao Akkinepally was appointed as Director on 11 Sep 2025. Priyanka Mahadevan ceased to be Additional Director on 26 Sep 2023. Astrazeneca India has 28 board changes on record in total.
Astrazeneca India has 9 MSME Form 1 returns on record between 2019 and 2023, listing 42 overdue payments to 12 micro and small suppliers. The latest return was filed on 28 Aug 2023.
Astrazeneca India can be reached through the website astrazeneca.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Astrazeneca India is at Block A Neville Tower 11th Floor Ramanujan It SEZ Taramani, Chennai, Tamil Nadu, India – 600113.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
